Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-09 in GNE Myopathy
NCT04671472Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aceneuramic acid in GNE myopathy (HIBM), sponsored by Nobelpharma Co., Ltd.. Started Feb 2021; status: completed.
02
Drugs
aceneuramic acid
03
Conditions
GNE myopathy (HIBM)
Beyond the preview
Go deeper on NCT04671472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04671472.